全球肠道疾病检测-治疗市场 – 行业趋势及 2029 年预测

市场分析与洞察全球肠道疾病检测-治疗市场

Data Bridge Market Research 分析称，肠道疾病检测-治疗市场在 2022-2029 年的预测期内将以 4.30% 的复合年增长率增长。由于主要市场参与者正专注于开发有助于医生和患者更好地提供医疗服务的产品，预计该市场在资本化方面将迅速扩张。

肠道疾病是由寄生虫、病毒和细菌等各种微生物引起的肠道疾病。这些微生物常见于各种食品和水体中，并且这种疾病类别在个体之间也是可以传播的。肠道疾病检测和治疗是指市场参与者为减少或消除肠道疾病对人体的影响而提供的各种诊断和治疗解决方案。

在预测期内，患有目标疾病的患者数量不断增加将成为肠道疾病检测-治疗市场增长的重要驱动力。基于先进技术而非传统方法的更高质量产品的可用性也推动了市场的增长。此外，政府为提高人民生活水平而加大的干预力度预计将对市场产生积极影响。政府主要负责将趋势从传统诊断方法转向先进方法。

肠道疾病检测市场的发展受到设备和劳动力成本高昂以及临床诊断对复杂实验室条件的强制性要求的制约。预计这些困难将在未来随着各种先进低成本技术的发展而得到克服，例如酶联免疫吸附试验 (ELISA) 和聚合酶链式反应 (PCR)。

This enteric disease testing-treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on enteric disease testing-treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Enteric Disease Testing-Treatment Market Scope and Market Size

Enteric disease testing - treatment market is segmented on the basis of disease type, therapeutics, testing technology and end user. Each individual segment’s growth is analysed and these insights are subsequently considered before providing you with the market overview which can help you in understanding and identification of your core applications in the broad market.

• On the basis of disease type, the enteric disease testing - treatment market has been segmented into bacterial enteric diseases, viral enteric diseases and parasitic enteric diseases. Bacterial enteric diseases have been further segmented into C.difficile infection, campylobacteriosis, cholera, E.coli infection, H.pylori infection, salmonellosis and shigellosis. Viral enteric diseases have been sub-segmented into rotavirus infection and norovirus infection. Parasitic enteric diseases have segmented into amebiasis, cryptosporidiosis and giardiasis.
• Based on therapeutics, the enteric disease testing - treatment market has been segmented into campylobacter, cryptosporidium, E-Coli, enteroviruses, RhinoViruses, RotaVirus (REOVIRUS), salmonellosis and shigellosis.
• Enteric disease testing-treatment market has been segmented on the basis of testing technology into molecular diagnostics, monoclonal antibodies, immunoassays, differential light scanning, information technology, artificial intelligence (AI), liposomes, flow cytometry, chromatography, diagnostic imaging, gel microdroplets, others
• Based on end user, the enteric disease testing-treatment market has been segmented into hospitals, diagnostic laboratories and physician offices.

Enteric Disease Testing-Treatment Market Country Level Analysis

The enteric disease testing-treatment market is analysed and market size insights and trends are provided by country, disease type, therapeutics, testing technology and end user as referenced above.

The countries covered in the enteric disease testing-treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific will be the most dominant region for the enteric disease testing-treatment market, with the majority of the population living in urban areas suffering from some form of enteric disease. This population is also migrating to cities, increasing demand for higher-quality healthcare services such as diagnostic products, treatment, and other solutions.

The country section of the enteric disease testing-treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The enteric disease testing-treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for enteric disease testing-treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the enteric disease testing-treatment market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Enteric Disease Testing-Treatment Market Share Analysis

The enteric disease testing-treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to enteric disease testing-treatment market.

肠道疾病检测-治疗市场的一些主要参与者包括雅培 (Abbott)、BD、Biomerica, Inc.、bioMérieux SA、Bio-Rad Laboratories, Inc.、Cepheid、CorisBioconcept SPRL、DIASORIN SpA、Meridian Bioscience, Inc.、Quest Diagnostics Incorporated、Trinity Biotech Ireland、Thermo Fisher Scientific Inc.、Mobidiag Ltd.、R-Biopharm、GlaxoSmithKline plc、Bharat Biotech、Sanofi、Janssen Global Services, LLC、Eli Lilly and Company、IDL Biotech AB (publ)、默克公司 (Merck & Co., Inc.)、诺华公司 (Novartis AG) 和武田制药有限公司 (Takeda Pharmaceutical Company Limited) 等。

SKU-24757